1412976-18-1

Basic information

• Product Name: methyl (1aRS,7bSR)-5-amino-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate
• Synonyms: methyl (1aRS,7bSR)-5-amino-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate;Methyl 5-Amino-1,1A,2,7B- Tetrahydrocyclopropa[C]Chromene- 4-Carboxylate;Methyl 5-Amino-1,1A,2,7B-Tetrahydrocyclopropa[C]Chromene-4-Carboxylate(WX106460)
• CAS NO: 1412976-18-1
• Molecular Formula: C12H13NO3
• Molecular Weight: 219.23652
• Mol File: 1412976-18-1.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: methyl (1aRS,7bSR)-5-amino-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (1aRS,7bSR)-5-amino-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate(1412976-18-1)
• EPA Substance Registry System: methyl (1aRS,7bSR)-5-amino-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate(1412976-18-1)

Safety Data

• Hazardous Substances Data: 1412976-18-1(Hazardous Substances Data)

Upstream product

• 64241-01-6 methyl 2-amino-6-hydroxybenzoate 
• 1356113-52-4 methyl 2-(2,2-dimethylpropionylamino)-6-hydroxybenzoate 
• 1412976-28-3 methyl 2-(2,2-dimethylpropionylamino)-6-(prop-2-ynyloxy)benzoate 
• 1412976-26-1 methyl 7-(2,2-dimethylpropionylamino)-2H-chromene-8-carboxylate 
• 1412976-24-9 methyl 1,1-dibromo-5-(2,2-dimethylpropionylamino)-1,1a,2,7b-tetrahydrocyclopropa-[c]chromene-4-carboxylate 
• 1412976-20-5 methyl 5-(2,2-dimethylpropionylamino)-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 

Downstream Products

• 1609200-94-3 methyl (1aR,7bS)-5-[2-(2-diethylaminomethylcyclopropyl)-4-fluorobenzenesulfonylamino]-1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-4-carboxylate 
• 1609201-09-3 methyl (1aR,7bS)-5-{4-fluoro-2-[(R)-1-(trifluoroacetyl)pyrrolidin-3-ylmethyl]benzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1609201-08-2 methyl (1aR,7bS)-5-[4-fluoro-2-((R)-pyrrolidin-3-ylmethyl)benzenesulfonylamino]-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1609201-11-7 methyl (1aR,7bS)-5-{4-fluoro-2-[(S)-1-(trifluoroacetyl)pyrrolidin-3-ylmethyl]benzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1609201-14-0 methyl (1aR,7bS)-5-{4-fluoro-2-[(R)-1-(2-hydroxy-2-methylpropyl)pyrrolidin-3-ylmethyl]benzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1412979-37-3 methyl (1aR,7bS)-5-[2-(1-ethylpiperidin-3-ylmethyl)-4-fluorobenzene-sulfonylamino]-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1609201-33-3 methyl (1aR,7bS)-5-{(2-[(R)-1-(2-tert-butyldimethylsilyloxyethyl)pyrrolidin-3-ylmethyl]-4-fluorobenzenesulfonylamino)}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1609201-32-2 methyl (1aR,7bS)-5-{4-fluoro-2-[(R)-1-(2-hydroxyethyl)pyrrolidin-3-ylmethyl]benzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1609201-39-9 methyl (1aR,7bS)-5-{N-[2-((Z)-3-hydroxyprop-1-enyl)-4-fluorobenzenesulfonyl]-N-(methoxycarbonyl)amino}-1,1a,2,7b-tetrahydrocyclopropa-[c]chromene-4-carboxylate 
• 1609201-40-2 methyl (1aR,7bS)-5-[N-(2-bromo-4-fluorobenzenesulfonyl)-N-(methoxycarbonyl)amino]-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1609200-74-9 (1aR,7bS)-5-[2-((R)-1-ethylpiperidin-3-ylmethyl)-4-fluorobenzenesulfonylamino]-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylic acid 
• 1609200-75-0 (1aR,7bS)-5-[2-((S)-1-ethylpiperidin-3-ylmethyl)-4-fluorobenzenesulfonylamino]-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylic acid 
• 1609201-45-7 tert-butyl (S)-2-((Z)-2-{5-fluoro-2-[(1aR,7bS)-4-methoxycarbonyl-1,1a,2,7b-tetrahydrocyclopropa[c]chromen-5-ylsulfamoyl]phenyl}ethenyl)pyrrolidine-1-carboxylate 
• 1609201-44-6 methyl (1aR,7bS)-5-{4-fluoro-2-[(Z)-2-((S)-pyrrolidin-2-yl)ethenyl]-benzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 

Relevant articles and documents

TRICYCLIC COMPOUNDS FOR USE IN THE TREATMENT AND/OR CONTROL OF OBESITY

The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against me